Tags

Type your tag names separated by a space and hit enter

Hendra and Nipah infection: emerging paramyxoviruses.
Virus Res. 2013 Nov 06; 177(2):119-26.VR

Abstract

Since their first emergence in mid 1990s henipaviruses continued to re emerge in Australia and South East Asia almost every year. In total there has been more than 12 Nipah and 48 Hendra virus outbreaks reported in South East Asia and Australia, respectively. These outbreaks are associated with significant economic and health damages that most high risks countries (particularly in South East Asia) cannot bear the burden of such economical threats. Up until recently, there were no actual therapeutics available to treat or prevent these lethal infections. However, an international collaborative research has resulted in the identification of a potential equine Hendra vaccine capable of providing antibody protection against Hendra virus infections. Consequently, with the current findings and after nearly 2 decades since their first detection, are we there yet? This review recaps the chronicle of the henipavirus emergence and briefly evaluates potential anti-henipavirus vaccines and antivirals.

Authors+Show Affiliations

Department of Microbiology, School of Medicine, Nursing and Health Sciences, Monash University, Wellington Road, Clayton, VIC 3800, Australia; Department of Pharmacology, College of Pharmacy, Qassim University, P.O. Box 6800, Buraidah 51452, Saudi Arabia. Electronic address: mo.aljofan@monash.edu.au.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

23954578

Citation

Aljofan, Mohamad. "Hendra and Nipah Infection: Emerging Paramyxoviruses." Virus Research, vol. 177, no. 2, 2013, pp. 119-26.
Aljofan M. Hendra and Nipah infection: emerging paramyxoviruses. Virus Res. 2013;177(2):119-26.
Aljofan, M. (2013). Hendra and Nipah infection: emerging paramyxoviruses. Virus Research, 177(2), 119-26. https://doi.org/10.1016/j.virusres.2013.08.002
Aljofan M. Hendra and Nipah Infection: Emerging Paramyxoviruses. Virus Res. 2013 Nov 6;177(2):119-26. PubMed PMID: 23954578.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Hendra and Nipah infection: emerging paramyxoviruses. A1 - Aljofan,Mohamad, Y1 - 2013/08/13/ PY - 2013/06/20/received PY - 2013/08/01/revised PY - 2013/08/02/accepted PY - 2013/8/20/entrez PY - 2013/8/21/pubmed PY - 2014/5/6/medline KW - HeV KW - Hendra virus KW - Henipavirus KW - IFN KW - NiV KW - Nipah virus KW - interferon SP - 119 EP - 26 JF - Virus research JO - Virus Res VL - 177 IS - 2 N2 - Since their first emergence in mid 1990s henipaviruses continued to re emerge in Australia and South East Asia almost every year. In total there has been more than 12 Nipah and 48 Hendra virus outbreaks reported in South East Asia and Australia, respectively. These outbreaks are associated with significant economic and health damages that most high risks countries (particularly in South East Asia) cannot bear the burden of such economical threats. Up until recently, there were no actual therapeutics available to treat or prevent these lethal infections. However, an international collaborative research has resulted in the identification of a potential equine Hendra vaccine capable of providing antibody protection against Hendra virus infections. Consequently, with the current findings and after nearly 2 decades since their first detection, are we there yet? This review recaps the chronicle of the henipavirus emergence and briefly evaluates potential anti-henipavirus vaccines and antivirals. SN - 1872-7492 UR - https://www.unboundmedicine.com/medline/citation/23954578/Hendra_and_Nipah_infection:_emerging_paramyxoviruses_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0168-1702(13)00265-7 DB - PRIME DP - Unbound Medicine ER -